Home » Global Markets Direct
Global Markets Direct Market Research Reports
Gram-Positive Bacterial Infections - Pipeline Review, H1 2013
Gram-Positive Bacterial Infections - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Gram-Positive Bacterial Infections - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Gram-Positive Bacterial Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Gram-Positive Bacterial Infections. Gram-Positive Bacterial Infections - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from ...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Cutaneous T-Cell Lymphoma - Pipeline Review, H1 2013
Cutaneous T-Cell Lymphoma - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Cutaneous T-Cell Lymphoma - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Cutaneous T-Cell Lymphoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cutaneous T-Cell Lymphoma. Cutaneous T-Cell Lymphoma - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specifi...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Burns - Pipeline Review, H1 2013
Burns - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Burns - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Burns, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Burns. Burns - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team.Note*: Certain sections i...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Indolent Lymphoma - Pipeline Review, H1 2013
Indolent Lymphoma - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Indolent Lymphoma - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Indolent Lymphoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Indolent Lymphoma. Indolent Lymphoma - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by G...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Myelofibrosis - Pipeline Review, H1 2013
Myelofibrosis - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Myelofibrosis - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Myelofibrosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Myelofibrosis. Myelofibrosis - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Osteosarcoma - Pipeline Review, H1 2013
Osteosarcoma - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Osteosarcoma - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Osteosarcoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Osteosarcoma. Osteosarcoma - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs tea...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Psychiatric Disorders - Pipeline Review, H1 2013
Psychiatric Disorders - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Psychiatric Disorders - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Psychiatric Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Psychiatric Disorders. Psychiatric Disorders - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party source...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2500
Published By: Global Markets Direct
Price: $2500
Waldenstrom Macroglobulinemia - Pipeline Review, H1 2013
Waldenstrom Macroglobulinemia - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Waldenstrom Macroglobulinemia - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Waldenstrom Macroglobulinemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Waldenstrom Macroglobulinemia. Waldenstrom Macroglobulinemia - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites ...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Post Menopausal Osteoporosis - Pipeline Review, H1 2013
Post Menopausal Osteoporosis - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Post Menopausal Osteoporosis - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Post Menopausal Osteoporosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Post Menopausal Osteoporosis. Post Menopausal Osteoporosis - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and i...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2013
Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Post-Traumatic Stress Disorder (PTSD), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Post-Traumatic Stress Disorder (PTSD). Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Septic Shock - Pipeline Review, H1 2013
Septic Shock - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Septic Shock - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Septic Shock, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Septic Shock. Septic Shock - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs tea...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Streptococcal Infections - Pipeline Review, H1 2013
Streptococcal Infections - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Streptococcal Infections - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Streptococcal Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Streptococcal Infections. Streptococcal Infections - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific thi...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Ischemic Stroke - Pipeline Review, H1 2013
Ischemic Stroke - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Ischemic Stroke - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Ischemic Stroke, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Ischemic Stroke. Ischemic Stroke - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Mark...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Choroidal Neovascularization - Pipeline Review, H1 2013
Choroidal Neovascularization - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Choroidal Neovascularization - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Choroidal Neovascularization, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Choroidal Neovascularization. Choroidal Neovascularization - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and i...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2013
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura). Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, Half Year is built using dat...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Diphtheria - Pipeline Review, H1 2013
Diphtheria - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Diphtheria - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Diphtheria, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Diphtheria. Diphtheria - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team....
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Metastatic Lung Cancer - Pipeline Review, H1 2013
Metastatic Lung Cancer - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Metastatic Lung Cancer - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Metastatic Lung Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Metastatic Lung Cancer. Metastatic Lung Cancer - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party s...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Uterine Cancer - Pipeline Review, H1 2013
Uterine Cancer - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Uterine Cancer - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Uterine Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Uterine Cancer. Uterine Cancer - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets D...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Rabies - Pipeline Review, H1 2013
Rabies - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Rabies - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Rabies, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Rabies. Rabies - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team.Note*: Certain secti...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Chronic Plaque Psoriasis - Pipeline Review, H1 2013
Chronic Plaque Psoriasis - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Chronic Plaque Psoriasis - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Chronic Plaque Psoriasis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Chronic Plaque Psoriasis. Chronic Plaque Psoriasis - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific thi...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Neuroendocrine Tumors - Pipeline Review, H1 2013
Neuroendocrine Tumors - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Neuroendocrine Tumors - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Neuroendocrine Tumors, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Neuroendocrine Tumors. Neuroendocrine Tumors - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party source...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Partial Seizure - Pipeline Review, H1 2013
Partial Seizure - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Partial Seizure - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Partial Seizure, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Partial Seizure. Partial Seizure - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Mark...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Sarcopenia - Pipeline Review, H1 2013
Sarcopenia - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Sarcopenia - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Sarcopenia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Sarcopenia. Sarcopenia - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team....
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H1 2013
Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Interstitial Cystitis (Painful Bladder Syndrome), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Interstitial Cystitis (Painful Bladder Syndrome). Interstitial Cystitis (Painful Bladder Syndrome) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites,...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Pruritus - Pipeline Review, H1 2013
Pruritus - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Pruritus - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Pruritus, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Pruritus. Pruritus - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team.Note*: Cer...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2013
B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for B-Cell Chronic Lymphocytic Leukemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for B-Cell Chronic Lymphocytic Leukemia. B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases ...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Bronchopulmonary Dysplasia - Pipeline Review, H1 2013
Bronchopulmonary Dysplasia - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Bronchopulmonary Dysplasia - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Bronchopulmonary Dysplasia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Bronchopulmonary Dysplasia. Bronchopulmonary Dysplasia - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-sp...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Friedreich Ataxia - Pipeline Review, H1 2013
Friedreich Ataxia - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Friedreich Ataxia - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Friedreich Ataxia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Friedreich Ataxia. Friedreich Ataxia - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by G...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Secondary Hyperparathyroidism - Pipeline Review, H1 2013
Secondary Hyperparathyroidism - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Secondary Hyperparathyroidism - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Secondary Hyperparathyroidism, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Secondary Hyperparathyroidism. Secondary Hyperparathyroidism - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites ...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Burkitt Lymphoma - Pipeline Review, H1 2013
Burkitt Lymphoma - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Burkitt Lymphoma - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Burkitt Lymphoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Burkitt Lymphoma. Burkitt Lymphoma - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
H3N2 Infection - Pipeline Review, H1 2013
H3N2 Infection - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'H3N2 Infection - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for H3N2 Infection, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for H3N2 Infection. H3N2 Infection - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets D...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Memory Impairment - Pipeline Review, H1 2013
Memory Impairment - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Memory Impairment - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Memory Impairment, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Memory Impairment. Memory Impairment - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by G...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Percutaneous Coronary Intervention - Pipeline Review, H1 2013
Percutaneous Coronary Intervention - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Percutaneous Coronary Intervention - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Percutaneous Coronary Intervention, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Percutaneous Coronary Intervention. Percutaneous Coronary Intervention - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from ...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Thymus Cancer - Pipeline Review, H1 2013
Thymus Cancer - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Thymus Cancer - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Thymus Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Thymus Cancer. Thymus Cancer - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Anesthetic Effect - Pipeline Review, H1 2013
Anesthetic Effect - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Anesthetic Effect - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Anesthetic Effect, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Anesthetic Effect. Anesthetic Effect - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by G...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Athlete's Foot (Tinea Pedis) - Pipeline Review, H1 2013
Athlete's Foot (Tinea Pedis) - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Athlete's Foot (Tinea Pedis) - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Athlete's Foot (Tinea Pedis), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Athlete's Foot (Tinea Pedis). Athlete's Foot (Tinea Pedis) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and i...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Cardiomyopathy - Pipeline Review, H1 2013
Cardiomyopathy - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Cardiomyopathy - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Cardiomyopathy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cardiomyopathy. Cardiomyopathy - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets D...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2013
Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Chagas Disease (American Trypanosomiasis), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Chagas Disease (American Trypanosomiasis). Chagas Disease (American Trypanosomiasis) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentation...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Female Hypoactive Sexual Desire Disorder - Pipeline Review, H1 2013
Female Hypoactive Sexual Desire Disorder - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Female Hypoactive Sexual Desire Disorder - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Female Hypoactive Sexual Desire Disorder, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Female Hypoactive Sexual Desire Disorder. Female Hypoactive Sexual Desire Disorder - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Hyperphosphatemia - Pipeline Review, H1 2013
Hyperphosphatemia - Pipeline Review, H1 2013SummaryGlobal Markets Directs, 'Hyperphosphatemia - Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Hyperphosphatemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hyperphosphatemia. Hyperphosphatemia - Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by G...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Breast Cancer Pipeline Review, H1 2013
Breast Cancer Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Breast Cancer Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Breast Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Breast Cancer. Breast Cancer Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press release...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2500
Published By: Global Markets Direct
Price: $2500
Ovarian Cancer Pipeline Review, H1 2013
Ovarian Cancer Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Ovarian Cancer Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Ovarian Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Ovarian Cancer. Ovarian Cancer Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press re...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2500
Published By: Global Markets Direct
Price: $2500
Lung Cancer Pipeline Review, H1 2013
Lung Cancer Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Lung Cancer Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Lung Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Lung Cancer. Lung Cancer Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/univ...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Inflammatory Bowel Disease Pipeline Review, H1 2013
Inflammatory Bowel Disease Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Inflammatory Bowel Disease Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Inflammatory Bowel Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Inflammatory Bowel Disease. Inflammatory Bowel Disease Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University website...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Chronic Pain Pipeline Review, H1 2013
Chronic Pain Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Chronic Pain Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Chronic Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Chronic Pain. Chronic Pain Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases fro...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Age Related Macular Degeneration Pipeline Review, H1 2013
Age Related Macular Degeneration Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Age Related Macular Degeneration Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Age Related Macular Degeneration, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Age Related Macular Degeneration. Age Related Macular Degeneration Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databas...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Depression Pipeline Review, H1 2013
Depression Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Depression Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Depression, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Depression. Depression Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Congestive Heart Failure (Heart Failure) Pipeline Review, H1 2013
Congestive Heart Failure (Heart Failure) Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Congestive Heart Failure (Heart Failure) Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Congestive Heart Failure (Heart Failure), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Congestive Heart Failure (Heart Failure). Congestive Heart Failure (Heart Failure) Pipeline Review, Half Year is built using data and information sourced from Gl...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Squamous Cell Carcinoma Pipeline Review, H1 2013
Squamous Cell Carcinoma Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Squamous Cell Carcinoma Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Squamous Cell Carcinoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Squamous Cell Carcinoma. Squamous Cell Carcinoma Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Cystic Fibrosis Pipeline Review, H1 2013
Cystic Fibrosis Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Cystic Fibrosis Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Cystic Fibrosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cystic Fibrosis. Cystic Fibrosis Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured pre...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Glioma Pipeline Review, H1 2013
Glioma Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Glioma Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Glioma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Glioma. Glioma Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Wounds Pipeline Review, H1 2013
Wounds Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Wounds Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Wounds, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Wounds. Wounds Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Kidney Cancer (Renal Cell Cancer) Pipeline Review, H1 2013
Kidney Cancer (Renal Cell Cancer) Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Kidney Cancer (Renal Cell Cancer) Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Kidney Cancer (Renal Cell Cancer), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Kidney Cancer (Renal Cell Cancer). Kidney Cancer (Renal Cell Cancer) Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary da...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Traumatic Brain Injury Pipeline Review, H1 2013
Traumatic Brain Injury Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Traumatic Brain Injury Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Traumatic Brain Injury, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Traumatic Brain Injury. Traumatic Brain Injury Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, inve...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Sarcomas Pipeline Review, H1 2013
Sarcomas Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Sarcomas Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Sarcomas, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Sarcomas. Sarcomas Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Sepsis Pipeline Review, H1 2013
Sepsis Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Sepsis Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Sepsis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Sepsis. Sepsis Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from comp...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Sickle Cell Disease Pipeline Review, H1 2013
Sickle Cell Disease Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Sickle Cell Disease Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Sickle Cell Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Sickle Cell Disease. Sickle Cell Disease Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentati...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Alcohol Addiction Pipeline Review, H1 2013
Alcohol Addiction Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Alcohol Addiction Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Alcohol Addiction, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Alcohol Addiction. Alcohol Addiction Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and fe...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Pulmonary Arterial Hypertension Pipeline Review, H1 2013
Pulmonary Arterial Hypertension Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Pulmonary Arterial Hypertension Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Pulmonary Arterial Hypertension, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Pulmonary Arterial Hypertension. Pulmonary Arterial Hypertension Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, C...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Diabetic Macular Edema Pipeline Review, H1 2013
Diabetic Macular Edema Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Diabetic Macular Edema Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Diabetic Macular Edema, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Diabetic Macular Edema. Diabetic Macular Edema Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, inve...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Systemic Sclerosis (Scleroderma) Pipeline Review, H1 2013
Systemic Sclerosis (Scleroderma) Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Systemic Sclerosis (Scleroderma) Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Systemic Sclerosis (Scleroderma), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Systemic Sclerosis (Scleroderma). Systemic Sclerosis (Scleroderma) Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databas...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Liver Fibrosis Pipeline Review, H1 2013
Liver Fibrosis Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Liver Fibrosis Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Liver Fibrosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Liver Fibrosis. Liver Fibrosis Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press re...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Escherichia Coli Infections Pipeline Review, H1 2013
Escherichia Coli Infections Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Escherichia Coli Infections Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Escherichia Coli Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Escherichia Coli Infections. Escherichia Coli Infections Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University we...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Hyperlipidemia Pipeline Review, H1 2013
Hyperlipidemia Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Hyperlipidemia Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Hyperlipidemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hyperlipidemia. Hyperlipidemia Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press re...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Mild Cognitive Impairment Pipeline Review, H1 2013
Mild Cognitive Impairment Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Mild Cognitive Impairment Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Mild Cognitive Impairment, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Mild Cognitive Impairment. Mild Cognitive Impairment Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SE...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Acute Renal Failure (ARF) (Acute Kidney Injury) Pipeline Review, H1 2013
Acute Renal Failure (ARF) (Acute Kidney Injury) Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Acute Renal Failure (ARF) (Acute Kidney Injury) Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Acute Renal Failure (ARF) (Acute Kidney Injury), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acute Renal Failure (ARF) (Acute Kidney Injury). Acute Renal Failure (ARF) (Acute Kidney Injury) Pipeline Review, Half Year is built using d...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Bile Duct Cancer (Cholangiocarcinoma) Pipeline Review, H1 2013
Bile Duct Cancer (Cholangiocarcinoma) Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Bile Duct Cancer (Cholangiocarcinoma) Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Bile Duct Cancer (Cholangiocarcinoma) , complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Bile Duct Cancer (Cholangiocarcinoma) . Bile Duct Cancer (Cholangiocarcinoma) Pipeline Review, Half Year is built using data and information sourced from Global Markets ...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Ischemia Reperfusion Injury Pipeline Review, H1 2013
Ischemia Reperfusion Injury Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Ischemia Reperfusion Injury Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Ischemia Reperfusion Injury, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Ischemia Reperfusion Injury. Ischemia Reperfusion Injury Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University we...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
T-Cell Lymphomas Pipeline Review, H1 2013
T-Cell Lymphomas Pipeline Review, H1 2013
Summary
Global Markets Directs, 'T-Cell Lymphomas Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for T-Cell Lymphomas, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for T-Cell Lymphomas. T-Cell Lymphomas Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and feature...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Lysosomal Storage Disorder Pipeline Review, H1 2013
Lysosomal Storage Disorder Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Lysosomal Storage Disorder Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Lysosomal Storage Disorder, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Lysosomal Storage Disorder. Lysosomal Storage Disorder Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University website...
Published Date: Apr 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Schizophrenia - Pipeline Review, H1 2013
Schizophrenia Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Schizophrenia Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Schizophrenia, complete with latest updates, and special features on late -stage and discontinued projects. It also reviews key players involved in the therapeutic development for Schizophrenia. Schizophrenia Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releas...
Published Date: Mar 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Influenza - Pipeline Review, H1 2013
Influenza Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Influenza Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Influenza, complete with latest updates, and special features on late -stage and discontinued projects. It also reviews key players involved in the therapeutic development for Influenza. Influenza Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, inves...
Published Date: Mar 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Non -Hodgkin Lymphoma - Pipeline Review, H1 2013
Non -Hodgkin Lymphoma Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Non -Hodgkin Lymphoma Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Non -Hodgkin Lymphoma, complete with latest updates, and special features on late -stage and discontinued projects. It also reviews key players involved in the therapeutic development for Non -Hodgkin Lymphoma. Non -Hodgkin Lymphoma Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor...
Published Date: Mar 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Other Hematological Disorders - Pipeline Review, H1 2013
Other Hematological Disorders Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Other Hematological Disorders Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Other Hematological Disorders, complete with latest updates, and special features on late -stage and discontinued projects. It also reviews key players involved in the therapeutic development for Other Hematological Disorders. Other Hematological Disorders Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/Un...
Published Date: Mar 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Eosinophilic Esophagitis - Pipeline Review, H1 2013
Eosinophilic Esophagitis Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Eosinophilic Esophagitis Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Eosinophilic Esophagitis, complete with latest updates, and special features on late -stage and discontinued projects. It also reviews key players involved in the therapeutic development for Eosinophilic Esophagitis. Eosinophilic Esophagitis Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC fi...
Published Date: Mar 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Rosacea - Pipeline Review, H1 2013
Rosacea Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Rosacea Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Rosacea, complete with latest updates, and special features on late -stage and discontinued projects. It also reviews key players involved in the therapeutic development for Rosacea. Rosacea Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sit...
Published Date: Mar 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Acute Respiratory Distress Syndrome - Pipeline Review, H1 2013
Acute Respiratory Distress Syndrome Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Acute Respiratory Distress Syndrome Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Acute Respiratory Distress Syndrome, complete with latest updates, and special features on late -stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acute Respiratory Distress Syndrome. Acute Respiratory Distress Syndrome Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs pro...
Published Date: Mar 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Polycystic Kidney Disease - Pipeline Review, H1 2013
Polycystic Kidney Disease Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Polycystic Kidney Disease Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Polycystic Kidney Disease, complete with latest updates, and special features on late -stage and discontinued projects. It also reviews key players involved in the therapeutic development for Polycystic Kidney Disease. Polycystic Kidney Disease Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, S...
Published Date: Mar 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Bronchiectasis - Pipeline Review, H1 2013
Bronchiectasis Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Bronchiectasis Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Bronchiectasis, complete with latest updates, and special features on late -stage and discontinued projects. It also reviews key players involved in the therapeutic development for Bronchiectasis. Bronchiectasis Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press r...
Published Date: Mar 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Fatigue - Pipeline Review, H1 2013
Fatigue Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Fatigue Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Fatigue, complete with latest updates, and special features on late -stage and discontinued projects. It also reviews key players involved in the therapeutic development for Fatigue. Fatigue Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sit...
Published Date: Mar 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Leishmaniasis (Kala -Azar) - Pipeline Review, H1 2013
Leishmaniasis (Kala -Azar) Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Leishmaniasis (Kala -Azar) Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Leishmaniasis (Kala -Azar), complete with latest updates, and special features on late -stage and discontinued projects. It also reviews key players involved in the therapeutic development for Leishmaniasis (Kala -Azar). Leishmaniasis (Kala -Azar) Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC f...
Published Date: Mar 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Cachexia - Pipeline Review, H1 2013
Cachexia Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Cachexia Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Cachexia, complete with latest updates, and special features on late -stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cachexia. Cachexia Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/universit...
Published Date: Mar 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Allergic Conjunctivitis - Pipeline Review, H1 2013
Allergic Conjunctivitis Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Allergic Conjunctivitis Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Allergic Conjunctivitis, complete with latest updates, and special features on late -stage and discontinued projects. It also reviews key players involved in the therapeutic development for Allergic Conjunctivitis. Allergic Conjunctivitis Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investo...
Published Date: Mar 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Nosocomial Infections - Pipeline Review, H1 2013
Nosocomial Infections Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Nosocomial Infections Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Nosocomial Infections, complete with latest updates, and special features on late -stage and discontinued projects. It also reviews key players involved in the therapeutic development for Nosocomial Infections. Nosocomial Infections Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor...
Published Date: Mar 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Acromegaly - Pipeline Review, H1 2013
Acromegaly Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Acromegaly Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Acromegaly, complete with latest updates, and special features on late -stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acromegaly. Acromegaly Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company...
Published Date: Mar 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Female Sexual Dysfunction - Pipeline Review, H1 2013
Female Sexual Dysfunction Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Female Sexual Dysfunction Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Female Sexual Dysfunction, complete with latest updates, and special features on late -stage and discontinued projects. It also reviews key players involved in the therapeutic development for Female Sexual Dysfunction. Female Sexual Dysfunction Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filing...
Published Date: Mar 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Lung Disease - Pipeline Review, H1 2013
Lung Disease Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Lung Disease Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Lung Disease, complete with latest updates, and special features on late -stage and discontinued projects. It also reviews key players involved in the therapeutic development for Lung Disease. Lung Disease Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases fr...
Published Date: Mar 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Moderate Psoriasis - Pipeline Review, H1 2013
Moderate Psoriasis Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Moderate Psoriasis Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Moderate Psoriasis, complete with latest updates, and special features on late -stage and discontinued projects. It also reviews key players involved in the therapeutic development for Moderate Psoriasis. Moderate Psoriasis Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations ...
Published Date: Mar 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Perennial Allergic Rhinitis - Pipeline Review, H1 2013
Perennial Allergic Rhinitis Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Perennial Allergic Rhinitis Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Perennial Allergic Rhinitis, complete with latest updates, and special features on late -stage and discontinued projects. It also reviews key players involved in the therapeutic development for Perennial Allergic Rhinitis. Perennial Allergic Rhinitis Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University w...
Published Date: Mar 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Typhoid Fever - Pipeline Review, H1 2013
Typhoid Fever Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Typhoid Fever Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Typhoid Fever, complete with latest updates, and special features on late -stage and discontinued projects. It also reviews key players involved in the therapeutic development for Typhoid Fever. Typhoid Fever Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from c...
Published Date: Mar 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Klebsiella Pneumoniae Infections - Pipeline Review, H1 2013
Klebsiella Pneumoniae Infections Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Klebsiella Pneumoniae Infections Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Klebsiella Pneumoniae Infections, complete with latest updates, and special features on late -stage and discontinued projects. It also reviews key players involved in the therapeutic development for Klebsiella Pneumoniae Infections. Klebsiella Pneumoniae Infections Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databa...
Published Date: Mar 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Other Dermatological Disorders - Pipeline Review, H1 2013
Other Dermatological Disorders Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Other Dermatological Disorders Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Other Dermatological Disorders, complete with latest updates, and special features on late -stage and discontinued projects. It also reviews key players involved in the therapeutic development for Other Dermatological Disorders. Other Dermatological Disorders Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Compa...
Published Date: Mar 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Yellow Fever - Pipeline Review, H1 2013
Yellow Fever Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Yellow Fever Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Yellow Fever, complete with latest updates, and special features on late -stage and discontinued projects. It also reviews key players involved in the therapeutic development for Yellow Fever. Yellow Fever Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases fr...
Published Date: Mar 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Fracture - Pipeline Review, H1 2013
Fracture Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Fracture Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Fracture, complete with latest updates, and special features on late -stage and discontinued projects. It also reviews key players involved in the therapeutic development for Fracture. Fracture Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/universit...
Published Date: Mar 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Glomerulonephritis - Pipeline Review, H1 2013
Glomerulonephritis Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Glomerulonephritis Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Glomerulonephritis, complete with latest updates, and special features on late -stage and discontinued projects. It also reviews key players involved in the therapeutic development for Glomerulonephritis. Glomerulonephritis Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations ...
Published Date: Mar 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Post -Polycythemia Vera Myelofibrosis (PPV -MF) - Pipeline Review, H1 2013
Post -Polycythemia Vera Myelofibrosis (PPV -MF) Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Post -Polycythemia Vera Myelofibrosis (PPV -MF) Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Post -Polycythemia Vera Myelofibrosis (PPV -MF), complete with latest updates, and special features on late -stage and discontinued projects. It also reviews key players involved in the therapeutic development for Post -Polycythemia Vera Myelofibrosis (PPV -MF). Post -Polycythemia Vera Myelofibrosis (PPV -MF) Pipeline Review, Half Year is built using ...
Published Date: Mar 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Bacterial Pneumonia - Pipeline Review, H1 2013
Bacterial Pneumonia Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Bacterial Pneumonia Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Bacterial Pneumonia, complete with latest updates, and special features on late -stage and discontinued projects. It also reviews key players involved in the therapeutic development for Bacterial Pneumonia. Bacterial Pneumonia Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentat...
Published Date: Mar 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Deep Vein Thrombosis (DVT) - Pipeline Review, H1 2013
Deep Vein Thrombosis (DVT) Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Deep Vein Thrombosis (DVT) Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Deep Vein Thrombosis (DVT), complete with latest updates, and special features on late -stage and discontinued projects. It also reviews key players involved in the therapeutic development for Deep Vein Thrombosis (DVT). Deep Vein Thrombosis (DVT) Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websit...
Published Date: Mar 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Dementia Associated With Alzheimer's Disease - Pipeline Review, H1 2013
Dementia Associated With Alzheimer's Disease Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Dementia Associated With Alzheimer's Disease Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Dementia Associated With Alzheimer's Disease, complete with latest updates, and special features on late -stage and discontinued projects. It also reviews key players involved in the therapeutic development for Dementia Associated With Alzheimer's Disease. Dementia Associated With Alzheimer's Disease Pipeline Review, Half Year is built using data and inform...
Published Date: Mar 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
Bone Cancer - Pipeline Review, H1 2013
Bone Cancer Pipeline Review, H1 2013
Summary
Global Markets Directs, 'Bone Cancer Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Bone Cancer, complete with latest updates, and special features on late -stage and discontinued projects. It also reviews key players involved in the therapeutic development for Bone Cancer. Bone Cancer Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from co...
Published Date: Mar 2013
Published By: Global Markets Direct
Price: $2000
Published By: Global Markets Direct
Price: $2000
